InvestorsHub Logo

DewDiligence

02/28/22 10:03 AM

#241593 RE: DewDiligence #241592

VTRS -22% on today’s Biocon deal. Investors are apparently viewing the deal as an act of (balance-sheet) desperation by VTRS.